[Early diagnosis of plasma Alzheimer's disease]

Being able to diagnose Alzheimer’s for decades before symptoms appear is the goal of the ongoing study by the CIC Nanogune research center, a member of the BRTA alliance. They learn from a sample of plasma or cerebrospinal fluid whether the person has the disease or not. To do this, they use spectroscopy, microscopy and artificial intelligence.